Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:47 PM
Ignite Modification Date:
2025-12-24 @ 4:47 PM
NCT ID:
NCT05432050
Eligibility Criteria:
Inclusion Criteria:
* Patients ≥ 19 years need general anesthesia
* American Society of Anesthesiologists (ASA) Classification I, II
* Written informed consent
Exclusion Criteria:
* American Society of Anesthesiologists (ASA) Classification III, IV, V
* BMI \> 40kg/m\^2
* Past medical history of anaphylactic reaction to remimazolam, remifentanil, or other benzodiazepines.
* Administration of anxiolytics, antipsychotics, rifampicin, succinylcholine, neostigmine, flumazenil, and cyclosporin within the past 24 hours
* Benzodiazepine user (e.g. for seizure control)
* Transfer to intensive care unit after surgery
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT05432050
Study Brief:
Protocol Section:
NCT05432050